Does BIMEKIZUMAB-BKZX Cause Inappropriate schedule of product administration? 214 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 214 reports of Inappropriate schedule of product administration have been filed in association with BIMEKIZUMAB-BKZX. This represents 4.0% of all adverse event reports for BIMEKIZUMAB-BKZX.
214
Reports of Inappropriate schedule of product administration with BIMEKIZUMAB-BKZX
4.0%
of all BIMEKIZUMAB-BKZX reports
0
Deaths
11
Hospitalizations
How Dangerous Is Inappropriate schedule of product administration From BIMEKIZUMAB-BKZX?
Of the 214 reports, 11 (5.1%) required hospitalization.
Is Inappropriate schedule of product administration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIMEKIZUMAB-BKZX. However, 214 reports have been filed with the FAERS database.
What Other Side Effects Does BIMEKIZUMAB-BKZX Cause?
Product dose omission issue (694)
Psoriasis (621)
Drug ineffective (402)
Product availability issue (364)
Off label use (335)
Psoriatic arthropathy (301)
Injection site pain (263)
Therapy interrupted (252)
Hidradenitis (233)
Incorrect dose administered (209)
What Other Drugs Cause Inappropriate schedule of product administration?
ADAPALENE (16,473)
DUPILUMAB (14,927)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (12,546)
INSULIN GLARGINE (8,982)
INFLIXIMAB (6,847)
INFLIXIMAB-DYYB (5,977)
SECUKINUMAB (4,817)
DULAGLUTIDE (3,606)
VEDOLIZUMAB (3,259)
SACUBITRIL\VALSARTAN (2,870)
Which BIMEKIZUMAB-BKZX Alternatives Have Lower Inappropriate schedule of product administration Risk?
BIMEKIZUMAB-BKZX vs BINIMETINIB
BIMEKIZUMAB-BKZX vs BIOFLAVONOIDS
BIMEKIZUMAB-BKZX vs BIOTIN
BIMEKIZUMAB-BKZX vs BIPERIDEN
BIMEKIZUMAB-BKZX vs BIRCH TRITERPENES